AMTD Digital Inc - ADR (HKD) is higher by 5.69% Monday In Premarket Trading

Verve Therapeutics Inc (VERV) is up Monday morning, with the stock climbing 5.53% in pre-market trading to 12.79. VERV's short-term technical score of 23 indicates that the stock has traded less bullishly over the last month than 77% of stocks on the market. In the Biotechnology industry, which ranks 127 out of 146 industries, Verve Therapeutics Inc ranks higher than 39% of stocks. Verve Therapeutics Inc has risen 37.10% over the past month, closing at $9.41 on October 30. During this period of time, the stock fell as low as $9.29 and as high as $20.12. VERV has an average analyst recommendation of Strong Buy. The company has an average price target of $43.67.

VERV has an Overall Score of 41. Find out what this means to you and get the rest of the rankings on VERV!

See Full VERV Report

Verve Therapeutics Inc has a Long-Term Technical rank of 7. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 93% of the market scoring higher. In the Biotechnology industry which is number 128 by this metric, VERV ranks better than 128% of stocks.

Important Dates for Investors in VERV:

-Verve Therapeutics Inc is set to release earnings on 2024-02-05. Over the last 12 months, the company has reported EPS of $-3.09. -We do not have a set dividend date for Verve Therapeutics Inc at this time. Click Here To Get The Full Report on Verve Therapeutics Inc (VERV)